(2Z,4Z)-8-ethyl-N,4,8-trimethyl-6-[2-(4-methylcyclohexyl)prop-2-enylidene]cyclonona-2,4-dien-1-imine
C24H37N — CID 138749981
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2Z,4Z)-8-ethyl-N,4,8-trimethyl-6-[2-(4-methylcyclohexyl)prop-2-enylidene]cyclonona-2,4-dien-1-imine
(2Z,4Z)-8-ethyl-N,4,8-trimethyl-6-[2-(4-methylcyclohexyl)prop-2-enylidene]cyclonona-2,4-dien-1-imine (PubChem CID 138749981) has the molecular formula C24H37N and a molecular weight of 339.57 g/mol. Its IUPAC name is (2Z,4Z)-8-ethyl-N,4,8-trimethyl-6-[2-(4-methylcyclohexyl)prop-2-enylidene]cyclonona-2,4-dien-1-imine.
Molecular Properties
| Compound Name | (2Z,4Z)-8-ethyl-N,4,8-trimethyl-6-[2-(4-methylcyclohexyl)prop-2-enylidene]cyclonona-2,4-dien-1-imine |
|---|---|
| PubChem CID | 138749981 |
| Molecular Formula | C24H37N |
| Molecular Weight | 339.57 g/mol |
| Exact Mass | 339.29 |
| IUPAC Name | (2Z,4Z)-8-ethyl-N,4,8-trimethyl-6-[2-(4-methylcyclohexyl)prop-2-enylidene]cyclonona-2,4-dien-1-imine |
| SMILES | C=C(C=C1/C=C(C)\C=C/C(=N/C)CC(C)(CC)C1)C1CCC(C)CC1 |
| InChI | InChI=1S/C24H37N/c1-7-24(5)16-21(14-19(3)10-13-23(17-24)25-6)15-20(4)22-11-8-18(2)9-12-22/h10,13-15,18,22H,4,7-9,11-12,16-17H2,1-3,5-6H3/b13-10-,19-14-,21-15?,25-23- |
| InChIKey | QKCUHTSUFPDHRZ-ZCJXIHBXSA-N |
| XLogP | 7.08 |
| TPSA | 12.36 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 339.57 |
| LogP ≤ 5 | 7.08 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138749981 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.